Drug search by name

Revefenacin inhalation and Hepatic impairment

Result of checking the interaction of drug Revefenacin inhalation and disease Hepatic impairment for safety when used together.

Check result:

Revefenacin inhalation <> Hepatic impairment

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

The systemic exposure of revefenacin is unchanged while that of its active metabolite is increased in subjects with moderate hepatic impairment. The safety of revefenacin has not been evaluated in COPD patients with mild-to-severe hepatic impairment, therefore revefenacin is not recommended in patients with any degree of hepatic impairment.

Revefenacin inhalation

Generic Name: revefenacin

Brand Name: Yupelri

Synonyms: Revefenacin (inhalation), Revefenacin

What is Revefenacin inhalation?